Upsurge in BCG vaccine induced lymphadenitis

Case series

V. Manju, Amrita Parida, Asha Hegde, Phalguna Kousikakatakam

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction: Tuberculosis is one of the serious healthcare concerns of the world today. The only vaccine available for tuberculosis till date is the BCG vaccine. It is one of the safest vaccine and is less commonly associated with adverse effects. However, recently we have seen an upsurge in number of BCG vaccine associated lymphadenitis in our hospital. Objective: To report the increase in number of BCG associated lymphadenitis cases in our hospital. Materials and methods: A total of ten cases of BCG associated lymphadenitis were seen in our hospital in the past one year. (May 2016 to April 2017) Data related to vaccination and the course of lymphadenitis was collected from the parents. Observations/Results: Out of the ten cases, 3 were vaccinated outside while the remaining infants were vaccinated in our hospital. Three out of the ten infants required intervention and remaining 7 were reassured and followed up, the swelling subsided in most of them. The most probable cause of the increased incidence in our hospital could be because of a particular batch of vaccine containing an altered strain/ change in the number of viable organism. Conclusion: We are reporting the cases as it might lead to an awareness among other practitioners and will also provide a scope for further studies. Increased surveillance and appropriate treatment guidelines for BCG vaccine associated lymphadenitis is the need of the hour.

Original languageEnglish
Pages (from-to)123-125
Number of pages3
JournalJournal of Young Pharmacists
Volume10
Issue number1
DOIs
Publication statusPublished - 01-01-2018

Fingerprint

BCG Vaccine
Lymphadenitis
Mycobacterium bovis
Vaccines
Tuberculosis Vaccines
Vaccination
Tuberculosis
Parents
Guidelines
Delivery of Health Care
Incidence

All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Manju, V. ; Parida, Amrita ; Hegde, Asha ; Kousikakatakam, Phalguna. / Upsurge in BCG vaccine induced lymphadenitis : Case series. In: Journal of Young Pharmacists. 2018 ; Vol. 10, No. 1. pp. 123-125.
@article{bd26305fbc2447cc9a4d7a970f683801,
title = "Upsurge in BCG vaccine induced lymphadenitis: Case series",
abstract = "Introduction: Tuberculosis is one of the serious healthcare concerns of the world today. The only vaccine available for tuberculosis till date is the BCG vaccine. It is one of the safest vaccine and is less commonly associated with adverse effects. However, recently we have seen an upsurge in number of BCG vaccine associated lymphadenitis in our hospital. Objective: To report the increase in number of BCG associated lymphadenitis cases in our hospital. Materials and methods: A total of ten cases of BCG associated lymphadenitis were seen in our hospital in the past one year. (May 2016 to April 2017) Data related to vaccination and the course of lymphadenitis was collected from the parents. Observations/Results: Out of the ten cases, 3 were vaccinated outside while the remaining infants were vaccinated in our hospital. Three out of the ten infants required intervention and remaining 7 were reassured and followed up, the swelling subsided in most of them. The most probable cause of the increased incidence in our hospital could be because of a particular batch of vaccine containing an altered strain/ change in the number of viable organism. Conclusion: We are reporting the cases as it might lead to an awareness among other practitioners and will also provide a scope for further studies. Increased surveillance and appropriate treatment guidelines for BCG vaccine associated lymphadenitis is the need of the hour.",
author = "V. Manju and Amrita Parida and Asha Hegde and Phalguna Kousikakatakam",
year = "2018",
month = "1",
day = "1",
doi = "10.5530/jyp.2018.10.27",
language = "English",
volume = "10",
pages = "123--125",
journal = "Journal of Young Pharmacists",
issn = "0975-1483",
publisher = "E-Flow Medknow Publications",
number = "1",

}

Upsurge in BCG vaccine induced lymphadenitis : Case series. / Manju, V.; Parida, Amrita; Hegde, Asha; Kousikakatakam, Phalguna.

In: Journal of Young Pharmacists, Vol. 10, No. 1, 01.01.2018, p. 123-125.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Upsurge in BCG vaccine induced lymphadenitis

T2 - Case series

AU - Manju, V.

AU - Parida, Amrita

AU - Hegde, Asha

AU - Kousikakatakam, Phalguna

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Introduction: Tuberculosis is one of the serious healthcare concerns of the world today. The only vaccine available for tuberculosis till date is the BCG vaccine. It is one of the safest vaccine and is less commonly associated with adverse effects. However, recently we have seen an upsurge in number of BCG vaccine associated lymphadenitis in our hospital. Objective: To report the increase in number of BCG associated lymphadenitis cases in our hospital. Materials and methods: A total of ten cases of BCG associated lymphadenitis were seen in our hospital in the past one year. (May 2016 to April 2017) Data related to vaccination and the course of lymphadenitis was collected from the parents. Observations/Results: Out of the ten cases, 3 were vaccinated outside while the remaining infants were vaccinated in our hospital. Three out of the ten infants required intervention and remaining 7 were reassured and followed up, the swelling subsided in most of them. The most probable cause of the increased incidence in our hospital could be because of a particular batch of vaccine containing an altered strain/ change in the number of viable organism. Conclusion: We are reporting the cases as it might lead to an awareness among other practitioners and will also provide a scope for further studies. Increased surveillance and appropriate treatment guidelines for BCG vaccine associated lymphadenitis is the need of the hour.

AB - Introduction: Tuberculosis is one of the serious healthcare concerns of the world today. The only vaccine available for tuberculosis till date is the BCG vaccine. It is one of the safest vaccine and is less commonly associated with adverse effects. However, recently we have seen an upsurge in number of BCG vaccine associated lymphadenitis in our hospital. Objective: To report the increase in number of BCG associated lymphadenitis cases in our hospital. Materials and methods: A total of ten cases of BCG associated lymphadenitis were seen in our hospital in the past one year. (May 2016 to April 2017) Data related to vaccination and the course of lymphadenitis was collected from the parents. Observations/Results: Out of the ten cases, 3 were vaccinated outside while the remaining infants were vaccinated in our hospital. Three out of the ten infants required intervention and remaining 7 were reassured and followed up, the swelling subsided in most of them. The most probable cause of the increased incidence in our hospital could be because of a particular batch of vaccine containing an altered strain/ change in the number of viable organism. Conclusion: We are reporting the cases as it might lead to an awareness among other practitioners and will also provide a scope for further studies. Increased surveillance and appropriate treatment guidelines for BCG vaccine associated lymphadenitis is the need of the hour.

UR - http://www.scopus.com/inward/record.url?scp=85042544069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042544069&partnerID=8YFLogxK

U2 - 10.5530/jyp.2018.10.27

DO - 10.5530/jyp.2018.10.27

M3 - Article

VL - 10

SP - 123

EP - 125

JO - Journal of Young Pharmacists

JF - Journal of Young Pharmacists

SN - 0975-1483

IS - 1

ER -